diagnostic:Melanoma. Diagnostic abroad
Multiple myeloma is a variant of the malignant tumor lesion of blood and lymphatic system. The disease occurs with symptoms of low immunity, bone loss, kidney and nervous system damage. Myeloma accounts for about 11% of all hematological malignancies. The risk of disease increases with age, and is more common among mature and elderly men. The two main types of this disease are characterized by the process prevalence: plasmacytoma is a local form with a single focus, and multiple myeloma is characterized by the presence of multiple tumor foci.
Multiple Myeloma Diagnostics Methods
During the first visit to the clinic, the doctor performs examination, reviews the case history and preliminary test findings (if any). Based on available data, the physician prescribes a physical examination and specific tests.
- complete blood count and urinalysis;
- blood chemistry;
- urine analysis for Bence-Jones protein: shows the anomaly of the lymphoid tissue;
- ultrasonography of the abdomen and kidneys;
- CT and MRI help identifying the foci of myeloma;
- aspiration biopsy of the bone marrow and ilium wing punch biopsy, followed by microscopic examination of the bone marrow punctate, are the basis of diagnostics and characterize the severity of the pathological process.
The myeloma diagnostics, depending on the severity of the patient's condition, is performed on an outpatient basis or in a hospital setting, where the patient is receiving palliative care and nursing services. At the end of the survey, an accurate diagnosis is established, and the patient is discharged with recommendations for further observation. If required, the specific treatment begins immediately after diagnosis.Hide